关于 "c-RET" 的结果33+ 个结果

Secretin (33-59), rat (TFA) 是由 27 个氨基酸组成的多肽，可以作用于分泌素 (secretin) 受体，能够增强胰腺的碳酸盐、酶和钾离子的分泌。

Secretin (28-54), human TFA 是由 27 个氨基酸组成的多肽，作用于人分泌素受体 (secretin receptor)。

Secretin (28-54), human 是由 27 个氨基酸组成的多肽，作用于分泌素受体 (secretin receptor)。

猪促胰液素（Porcine secretin acetate）（Porcine secretin acetate）是一种含有 27 个氨基酸的肽，作用于胰腺腺泡细胞和导管上皮细胞，刺激产生富含碳酸氢盐的液体。

A neuropeptide hormone

Secretin, canine 是一种内分泌激素，刺激分泌富含碳酸氢盐的胰液。Secretin, canine 可通过Src激酶依赖途径调节胃单层细胞的主要细胞功能和旁细胞通透性。

Secretoneurin, rat 是由分泌粒蛋白 II (SgII) 的蛋白水解过程产生的一种 33 个氨基酸多肽。Secretoneurin, rat 在体内和体外诱导大鼠纹状体多巴胺释放，对单核细胞和嗜酸性粒细胞有很强的趋化作用，而对粒细胞则没有。

A gastrointestinal hormone and neuropeptide

A neuropeptide hormone

Orexin A（人类、大鼠、小鼠）协调不同的中枢和外周过程。

Orexin A human, rat, mouse TFA 是一种 33 氨基酸兴奋性神经肽。Orexin A human, rat, mouse TFA 作用于 2 种特异性 G 蛋白偶联体 (GPCR):orexin-1 (OX1) 和 orexin-2 (OX2)。

A hypothalamic neuropeptide

A hypothalamic neuropeptide

Fluorogenic (FRET) substrate for pro-memapsin-2 containing the β-secretase site of the Swedish mutation of APP, SEVNLDAEF.

This fluorescent (FRET) peptide substrate contains the wild-type amyloid precursor protein (APP) β-secretase cleavage site. Mca-SEVKMDAEFRK(Dnp)RR- amide has been used for assaying β-secretase-like activity of thimet oligopeptidase (TOP, EC 3.4.24.15). The results suggested that TOP is a potential β-secretase candidate and is involved in the processing of APP in vivo. See also L-1905.

Intramolecularly quenched fluorescent, presenilin-dependent substrate for assaying γ-secretase activity. The FRET substrate has been used for partial purification and characterization of γ-secretase from post-mortem human brain.

A growth hormone secretagogue and GHS-R agonist

This peptide substrate corresponds to the 'Swedish' Lys-Met/Asn-Leu (K670N/M671L) mutation of the amyloid precursor protein (APP) β-secretase cleavage site. It has been used for assaying β-secretase activity.

Amyloid precursor protein (APP) β-secretase from human brain cleaves full-length APP at the amino terminus of the amyloid β-protein (Aβ) sequence, thus leading to the generation and extracellular release of β-cleaved soluble APP and a corresponding cell-associated carboxy-terminal fragment. The subsequent cleavage of the C-terminal fragment by γ-secretase(s) leads to the formation of Aβ. This new peptide represents a potent substrate analog inhibitor of APP β-secretase with IC?? = 30 nM.

A mutation very close to the β-secretase cleavage site of APP. The Icelandic mutation A2T of Aβ42 turned out to be less pathogenic than the native sequence. The precursor APP A673T was the first APP variant discovered in humans reducing the risk of Alzheimer's disease. A2T as well affects γ-secretase cleavage, the mutant was an inefficient substrate in a cell-based assay of the enzyme.

A mutation very close to the β-secretase cleavage site of APP (A673V). Contrary to the protective Icelandic mutation A2T, the recessive A2V mutation may increase the risk of Alzheimer's disease. Cantu et al. observed that APP A673V is associated with the early onset of AD-type dementia in homozygous individuals, whereas it has a protective effect in the heterozygous state.

Intramolecularly quenched fluorescent substrate containing the ortho-aminobenzoyl (Abz) / N-(2,4-dinitrophenyl)ethylenediamine (EDDnp) groups as the donor / acceptor pair. It corresponds to the Swedish-mutated (JMV2236) β-amyloid precursor protein (βAPP) sequence targeted by β-secretase BACE (β-site APP-cleaving activity). This FRET substrate is more selectively cleaved by BACE1 and BACE2 than by cathepsin D, a disintegrin and metalloprotease 10 (ADAM10), tumor necrosis α-converting enzyme (TACE), presenilin-1 (PS1), or presenilin-2 (PS2).

Intramolecularly quenched fluorescent substrate containing the ortho-aminobenzoyl (Abz) / N-(2,4-dinitrophenyl)ethylenediamine (EDDnp) groups as the donor / acceptor pair. It mimicks the wild-type (JMV2235) β-amyloid precursor protein (βAPP) sequence targeted by β-secretase BACE (β-site APP-cleaving activity). This FRET substrate is cleaved by BACE1, BACE2, and cathepsin D.

A sensitive fluorogenic (FRET) substrate developed for the analysis of γ-secretase from post mortem non-Alzheimer's and Alzheimer's disease human brain isolates.